Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antibody-Mediated Rejection”

98 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 98 results

Not applicableStudy completedNCT03098238
What this trial is testing

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation

Who this might be right for
Renal Transplantation
University Hospital, Montpellier 249
Not applicableUnknownNCT03815864
What this trial is testing

Antibodies and Liver Retransplantation

Who this might be right for
Liver Transplant FailureAntibody-mediated Rejection
London Health Sciences Centre 200
Testing effectiveness (Phase 2)Looking for participantsNCT06744647
What this trial is testing

Phase 2 Study of ALXN2030 in Patients With Antibody-Mediated Rejection After Kidney Transplantation

Who this might be right for
Antibody-Mediated RejectionKidney TransplantationBiopsy-proven Histologic Scores+1 more
Alexion Pharmaceuticals, Inc. 45
Not applicableStudy completedNCT05452317
What this trial is testing

Assess Burden of Disease Among Kidney Transplant Recipients With Chronic Active Antibody Mediated Rejection

Who this might be right for
Antibody-mediated Rejection in Kidney Transplant
CSL Behring 52
Testing effectiveness (Phase 2)Study completedNCT01134510
What this trial is testing

Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection

Who this might be right for
Kidney Transplantation
Stanley Jordan, MD 20
Testing effectiveness (Phase 2)Ended earlyNCT01630538
What this trial is testing

Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants

Who this might be right for
Antibody Mediated Rejection
University of Manitoba 4
Not applicableNot Yet RecruitingNCT07005687
What this trial is testing

Using MSCs for Chronic Active Antibody Mediated Rejection

Who this might be right for
Kidney Transplant Rejection
Shahid Beheshti University of Medical Sciences 10
Not applicableActive Not RecruitingNCT07316829
What this trial is testing

TRAnscriptional Profile of Peripheral Blood Cells in Patient With Chronic Kidney and Lung Rejection: Correlation With Response to Extracorporeal Photo-aphereSiS

Who this might be right for
Graft RejectionKidney TransplantationLung Transplantation+6 more
Fondazione IRCCS Policlinico San Matteo di Pavia 30
Post-approval studies (Phase 4)WithdrawnNCT02130817
What this trial is testing

Belatacept in Kidney Transplantation of Moderately Sensitized Patients

Who this might be right for
End Stage Renal DiseaseAntibody Mediated Rejection
University of Wisconsin, Madison
Early research (Phase 1)Ended earlyNCT01848301
What this trial is testing

Endothelial Injury and Development of Coronary Intimal Thickening After Heart Transplantation

Who this might be right for
Cardiac Allograft VasculopathyAntibody Mediated Rejection
Gladwin, Mark, MD 12
Testing effectiveness (Phase 2)Study completedNCT03380377
What this trial is testing

Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant

Who this might be right for
Antibody-mediated RejectionKidney Transplant; ComplicationsTransplant Glomerulopathy+3 more
Stanley Jordan, MD 10
Not applicableEnded earlyNCT02120482
What this trial is testing

Combined Apheresis for ABO-incompatible Transplantation - a Pilot Study

Who this might be right for
Decreased Immunologic ActivityAntibody-mediated Rejection
Medical University of Vienna 4
Not applicableNot Yet RecruitingNCT05779124
What this trial is testing

BAFF/APRIL in Kidney Transplant Rejection Risk Assessment

Who this might be right for
Kidney TransplantationKidney Transplant Rejection
First Affiliated Hospital, Sun Yat-Sen University 176
Not applicableNot Yet RecruitingNCT06774365
What this trial is testing

CARdiac Imaging and BIomarkers in the Diagnosis of Antibody Mediated Rejection in Heart Transplantation

Who this might be right for
Heart TransplantationRejection Heart TransplantHLA Antigens
IRCCS Azienda Ospedaliero-Universitaria di Bologna 683
Not applicableLooking for participantsNCT04870437
What this trial is testing

Impact of ExtraCorporeal Phototherapy (ECP) on Auxiliary Follicular T-lymphocytes and Circulating B-lymphocytes During Chronic AntiBody-Mediated Rejection in Kidney Transplantation.

Who this might be right for
Kidney Transplantation
University Hospital, Angers 30
Not applicableStudy completedNCT03737136
What this trial is testing

Comparison Between Bortezomib and Rituximab Plus Plasmapheresis in AMR

Who this might be right for
Antibody-mediated Rejection
Shahid Beheshti University of Medical Sciences 20
Very early researchWithdrawnNCT05862766
What this trial is testing

Isatuximab in Lung Transplant Recipients

Who this might be right for
Antibody-mediated RejectionAllosensitization
NYU Langone Health
Not applicableUnknownNCT06013358
What this trial is testing

DdcfDNA in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant Rejection
Seoul National University Hospital 200
Large-scale testing (Phase 3)Ended earlyNCT03994783
What this trial is testing

Transplant Antibody-Mediated Rejection: Guiding Effective Treatments

Who this might be right for
Kidney Transplant RejectionAntibody-mediated Rejection
Imperial College London 3
Testing effectiveness (Phase 2)Study completedNCT01567085
What this trial is testing

Safety & Efficacy Of Eculizumab In The Prevention Of AMR In Sensitized Recipients Of A Kidney Transplant From A Deceased Donor

Who this might be right for
Stage V Chronic Kidney Disease
Alexion Pharmaceuticals, Inc. 80
Load More Results